Download the Agenda

Speaker Information

 Justin Stebbing
Justin Stebbing Professor of Cancer Medicine and Medical Oncology Imperial College

Combination Therapies Focus Day

11:00 AM Synergy Between Modalities: Combining Immune Checkpoint Modulation With Chemotherapy

Although cancer chemotherapy has historically been considered immune suppressive, it is now accepted that certain chemotherapies can augment tumor immunity. The recent success of immune checkpoint inhibitors has renewed interest in immunotherapies, and in combining them with chemotherapy to achieve additive or synergistic clinical activity.
Attend this session to:
•    Discover Imperial College’s recent successes of combining immune checkpoint inhibitors with chemotherapy

Sponsorship Opportunities

Resource Center

Visit the Resource Center for complimentary industry related content!


Become a Pharma IQ Member and receive our weekly newsletter!